Related by context. Frequent words. (Click for all words.) 72 severe hypoglycemia 68 discontinuations due 68 acute coronary 66 treatment emergent adverse 65 thromboembolic events 64 placebo p = 64 hypoglycemia 64 thromboembolism 63 febrile neutropenia 63 hyperkalemia 63 myocardial infarctions 62 hypercalcemia 62 thrombotic events 62 acute myocardial infarction AMI 62 hypoglycaemia 62 placebo p 62 laboratory abnormalities 61 renal dysfunction 61 hypokalemia 61 renal insufficiency 61 leukopenia 59 rehospitalization 59 P = .# 59 unstable angina 59 HbA1c levels 59 peripheral edema 59 exacerbations 59 vertebral fracture 58 intracerebral hemorrhage 58 mg BID 58 myocardial infarction MI 58 myocardial infarction 58 stable angina 58 placebo 58 nasopharyngitis 58 lamotrigine 58 cerebrovascular 58 ST elevation myocardial 58 nonsignificant 57 % CI #.#-#.# [006] 57 confidence interval #.#-#.# 57 discontinuations 57 thrombotic 57 CINV 57 interferon alfa 57 p = #.# [002] 57 cardiogenic shock 57 mmol L 57 syncope 57 recurrent stroke 57 confidence interval CI 56 dysmenorrhea 56 vertebral fractures 56 decitabine 56 p = #.# [004] 56 venous thrombosis 56 peginterferon alfa 2a 56 cardiovascular mortality 56 fasting plasma glucose 56 hypocalcemia 56 VTE 56 unfractionated heparin 56 plus methotrexate 56 glipizide 56 amenorrhea 56 dyspnea 56 thrombocytopenia 56 microalbuminuria 56 ischemic 56 evaluable 56 left ventricular dysfunction 56 comorbid conditions 56 venous thromboembolism 56 reach statistical significance 56 Hypoglycemia 56 composite endpoint 56 events AEs 56 acute coronary syndrome 55 ventricular tachycardia 55 angioedema 55 orthostatic hypotension 55 LVEF 55 hepatotoxicity 55 angina pectoris 55 statistically significant reduction 55 uncontrolled hypertension 55 nonfatal heart 55 Median survival 55 lactic acidosis 55 patients receiving ERBITUX 55 severe renal impairment 55 ventricular arrhythmias 55 tamsulosin 55 myelosuppression 55 hypotension 55 diabetic neuropathic pain 55 sustained virologic response 55 creatinine clearance 55 gastrointestinal GI 55 hypersensitivity reactions 55 serum phosphorus